Welcome to P\S\L Group

Over 1 million visits a month
Click here to learn more

Doctors registered in 127 countries
Click here to learn more

FDA approves Amylin and Alkermes Bydureon - (Ref. Bloomberg; Mass High Tech; Xconomy; TheStreet; FDA; Amylin) FDA approves Pfizer's Inlyta for advanced kidney cancer - (Ref. The Wall Street Journal; NASDAQ; The Baltimore Sun; The Washington Post; Bloomberg; FDA; Pfizer) Infinity halts Phase II trial of saridegib in pancreatic cancer, shares plunge 45 percent - (Ref. Proactive Investors; The Wall Street Journal; Xconomy; CNBC; Business Wire) EU regulator ends probe into Servier's response to antitrust investigations - (Ref. Europa; BusinessWeek) Ranbaxy shares drop as analysts say FDA consent decree may affect generic versions of Actos, Nexium - (Ref. livemint.com; Bloomberg; Yahoo!News) More Industry News
Bedwetting Can Be Due to Undiagnosed Constipation in Children - (DGNews) FDA Approves Axitinib for Advanced Renal Cell Carcinoma - (DGNews) Chemoradiation Improves Outcomes in a Subset of Patients With Head and Neck Cancer: Presented at MHNCS - (DGDispatch) New Lung Cancer Assay Better Than Existing Methods at Predicting Survival After Surgery - (DGNews) Poorly Controlled Diabetes Affects Hearing Loss, Especially in Women - (DGNews) More Medical News
Privacy Policy \| All contents Copyright© 2012 P\S\L Group. All rights reserved.